MEN with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

PSMA antigen implicated in disease biology withcontinued expression following androgen receptor pathway inhibitor (ARPI) ...

Your body often gives subtle clues about internal changes long before it become serious. Finger clubbing is a small but ...

Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of therapy, 59% achieved PSA50 response and 32% achieved P ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about whether the agent belongs in the first-line setting.

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...

A new study published in JAMA Network Open by the Harvey L. Neiman Health Policy Institute reveals poverty, environmental ...

Learn the symptoms of bladder cancer —blood in the urine, pain, and irritation or obstruction when urinating —and when to see a healthcare provider.

The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...